Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain

Bone Marrow Transplant. 1998 Jun;21(11):1155-8. doi: 10.1038/sj.bmt.1701205.

Abstract

EBV-associated lymphoproliferative disorder (LPD) is a rare but serious complication in marrow transplant recipients. A 31-year-old Japanese woman in the second chronic phase of CML received an allogeneic BMT from her HLA 2-locus-incompatible 62-year-old father. Around day +200, she developed EBV-LPD of the right parieto-temporal lobe which caused slowly progressive left hemiparesis. Two courses of donor lymphocyte transfusions (DLT) of 10(6)CD3+ T cells/kg of body weight failed to suppress her central nervous system (CNS) EBV-LPD. The patient died of recurrent blastic crisis of CML. This case suggests that DLT may be ineffective for the treatment of CNS EBV-LPD.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bone Marrow Transplantation / adverse effects*
  • Brain Diseases / etiology*
  • Brain Diseases / pathology
  • Brain Diseases / therapy*
  • Fatal Outcome
  • Female
  • Graft vs Host Disease / etiology
  • Herpesvirus 4, Human / pathogenicity*
  • Humans
  • Leukemia, Myeloid, Chronic-Phase / therapy
  • Lymphocyte Transfusion*
  • Lymphoproliferative Disorders / etiology*
  • Lymphoproliferative Disorders / pathology
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Middle Aged
  • Tissue Donors*
  • Transplantation, Homologous